Deficient cytokine expression and neutrophil oxidative burst contribute to impaired cutaneous wound healing in diabetic, biofilm-containing chronic wounds

Wound Repair and Regeneration

Volumn 21, Issue 6, 2013, Pages 833-841

  Nguyen, Khang T ^a   Seth, Akhil K ^a   Hong, Seok J ^a   Geringer, Matthew R ^a   Xie, Ping ^a   Leung, Kai P ^b   Mustoe, Thomas A ^a   Galiano, Robert D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYTOKINE; INTERLEUKIN 1BETA; PSEUDOMONIC ACID; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL PROTEIN; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIAL LOAD; BIOFILM; CELLULITIS; CHRONIC WOUND; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIZATION; FEMALE; IMMUNE RESPONSE; INNATE IMMUNITY; MALE; MOLECULAR RECOGNITION; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY BURST; SIGNAL TRANSDUCTION; SKIN; SKIN INJURY; SKIN ULCER; WILD TYPE; WOUND DRESSING; WOUND HEALING; WOUND INFECTION; ANIMAL; CHRONIC DISEASE; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; ULCER;

ANIMALS; BACTERIAL PROTEINS; BIOFILMS; CHRONIC DISEASE; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION, BACTERIAL; INTERLEUKIN-1BETA; MALE; MICE; NEUTROPHILS; RESPIRATORY BURST; SIGNAL TRANSDUCTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; ULCER; WOUND HEALING; WOUND INFECTION;

EID: 84888133085     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12109     Document Type: Conference Paper

References (42)

1. Harrington C, Zagari MJ, Corea J, Klitenic J,. A cost analysis of diabetic lower-extremity ulcers. Diabetes Care 2000; 9: 1333-1338.
2. Falanga V,. Wound healing and its impairment in the diabetic foot. Lancet 2005; 366: 1736-1743.
3. Ferrier TM,. Comparative study of arterial disease in amputated lower limbs from diabetics and non-diabetics (with special reference to feet arteries). Med J Aust 1967; 1: 5-11.
4. Dinh T, Veves A,. Microcirculation of the diabetic foot. Curr Pharm Des 2005; 11: 2301-2309.
5. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H,. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002; 45: 1011-1016.
6. Muller M, Trocme C, Lardy B, Morel F, Halimi S, Benhamou PY,. Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing. Diabet Med 2008; 25: 419-426.
7. Oates A, Bowling FL, Boulton AJ, McBain AJ,. A molecular and culture-based assessment of the microbial diversity of diabetic chronic foot wounds and contralateral skin sites. J Clin Microbiol 2012; 50: 2263-2271.
8. James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, et al. Biofilms in chronic wounds. Wound Repair Regen 2008; 16: 37-44.
9. Costerton JW, Stewart PS, Greenberg EP,. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-1322.
10. Anderson GG, O'Toole GA,. Innate and induced resistance mechanisms of bacterial biofilms. Curr Top Microbiol Immunol 2008; 322: 85-105.
11. Kong KF, Vuong C, Otto M,. Staphylococcus quorum sensing in biofilm formation and infection. Int J Med Microbiol 2006; 296: 133-139.
12. Kirker KR, Secor PR, James GA, Fleckman P, Olerud JE, Stewart PS,. Loss of viability and induction of apoptosis in human keratinocytes exposed to Staphylococcus aureus biofilms in vitro. Wound Repair Regen 2009; 17: 690-699.
13. Parsek MR, Singh PK,. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 2003; 57: 677-701.
14. Bjarnsholt T, Kirketerp-Møller K, Jensen PØ, Madsen KG, Phipps R, Krogfelt K, et al. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 2008; 16: 2-10.
15. Zhao G, Hochwalt PC, Usui ML, Underwood RA, Singh PK, James GA, et al. Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds. Wound Repair Regen 2010; 18: 467-477.
16. Gurjala AN, Geringer MR, Seth AK, Hong SJ, Smeltzer MS, Galiano RD, et al. Development of a novel, highly quantitative in vivo model for the study of biofilm-impaired cutaneous wound healing. Wound Repair Regen 2011; 19: 400-410.
17. Kim JH, Stewart TP, Soltani-Bejnood M, Wang L, Fortuna JM, Mostafa OA, et al. Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice. J Endocrinol 2006; 191: 437-446.
18. Buck DW 2nd, Jin P, Geringer M, Hong SJ, Galiano RD, Mustoe TA,. The TallyHo polygenic mouse model of diabetes: implications in wound healing. Plast Reconstr Surg 2011; 128: 427e-437.
19. Dinh T, Tecilazich F, Kafanas A, Doupis J, Gnardellis C, Leal E, et al. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes 2012; 61: 2937-2947.
20. Bradley PP, Priebat DA, Christensen RD, Rothstein G,. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78: 206-209.
21. Mast BA, Schultz GS,. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen 1996; 4: 411-420.
22. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999; 7: 442-452.
23. Richard JL, Lavigne JP, Sotto A,. Diabetes and foot infection: more than double trouble. Diabetes Metab Res Rev 2012; 28 (Suppl. 1): 46-53.
24. Xu L, McLennan SV, Lo L, Natfaji A, Bolton T, Liu Y, et al. Bacterial load predicts healing rate in neuropathic diabetic foot ulcers. Diabetes Care 2007; 30: 378-380.
25. Goodarzi H, Trowbridge J, Gallo RL,. Innate immunity: a cutaneous perspective. Clin Rev Allergy Immunol 2007; 33: 15-26.
26. Gariboldi S, Palazzo M, Zanobbio L, Selleri S, Sommariva M, Sfondrini L, et al. Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of beta-defensin 2 via TLR2 and TLR4. J Immunol 2008; 181: 2103-2110.
27. Quinn GA, Cole AM,. Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium. Immunology 2007; 122: 80-89.
28. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, et al. CD36 is a sensor of diacylglycerides. Nature 2005; 433: 523-527.
29. Miller LS, O'Connell RM, Gutierrez MA, Pietras EM, Shahangian A, Gross CE, et al. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 2006; 24: 79-91.
30. Senter LH, Legrand EK, Laemmerhirt KE, Kiorpes TC,. Assessment of full-thickness wounds in the genetically diabetic mouse for suitability as a wound healing model. Wound Repair Regen 1995; 3: 351-358.
31. Lee YH, Chang JJ, Chien CT, Yang MC, Chien HF,. Antioxidant sol-gel improves cutaneous wound healing in streptozotocin-induced diabetic rats. Exp Diabetes Res 2012; 2012: 504693. doi: 10.1155/2012/504693.
32. Nathan CF,. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 1987; 80: 1550-1560.
33. Djeu JY, Matsushima K, Oppenheim JJ, Shiotsuki K, Blanchard DK,. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. J Immunol 1990; 144: 2205-2210.
34. Dularay B, Elson CJ, Clements-Jewery S, Damais C, Lando D,. Recombinant human interleukin-1 beta primes human polymorphonuclear leukocytes for stimulus-induced myeloperoxidase release. J Leukoc Biol 1990; 47: 158-163.
35. Borregaard N,. Neutrophils, from marrow to microbes. Immunity 2010; 33: 657-670.
36. Song E, Jaishankar GB, Saleh H, Jithpratuck W, Sahni R, Krishnaswamy G,. Chronic granulomatous disease: a review of the infectious and inflammatory complications. Clin Mol Allergy 2011; 9: 10.
37. Hatanaka E, Monteagudo PT, Marrocos MS, Campa A,. Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin Exp Immunol 2006; 146: 443-447.
38. Ohta N, Tsai JY, Secchi EF, Kador PF, Sato S,. Neutrophils in galactose-fed dogs: suppressed apoptosis and increased adhesion to retinal capillary endothelial cells. J Diabetes Complications 1999; 13: 151-158.
39. Hanses F, Park S, Rich J, Lee JC,. Reduced neutrophil apoptosis in diabetic mice during staphylococcal infection leads to prolonged Tnfα production and reduced neutrophil clearance. PLoS ONE 2011; 6: e23633.
40. Mowat A, Baum J,. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med 1971; 284: 621-627.
41. Segel GB, Halterman MW, Lichtman MA,. The paradox of the neutrophil's role in tissue injury. J Leukoc Biol 2011; 89: 359-372.
42. Dovi JV, He LK, DiPietro LA,. Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 2003; 73: 448-455.